Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise value
Mamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This strategic move, Honasa's second acquisition in under a year, signals a growing trend of consolidation in the beauty and personal care sector. Honasa aims to integrate science-backed skincare with nutraceuticals, addressing consumer demand for holistic wellness solutions. Fluence Pharma will become the ninth brand under Honasa's umbrella.
RSS News
Economic times
0 thoughts on “Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise value”
Leave a Reply
Your email address will not be published. Required fields are marked *
RECENT NEWS
- Inside India’s language conundrum
- 'Team India is the best...', every Pakistani will feel chilly after hearing this statement of the PAK coach; Know what to say
- Sai Sudarshan and Devdutt Padikkal dominate the second day, Sri Lankan bowlers take their breath; Robbed by a century
- 'Indus Waters Treaty remains suspended': India rebukes Pakistan rhetoric, affirms key condition
- Kamikaze drones, anti-tank missiles among Rs 52,000 crore defence procurement proposals approved by DAC
